SL Galetta

TL;DR: This paper developed guidelines for MS differential diagnosis, focusing on exclusion of potential MS mimics, diagnosis of common initial isolated clinical syndromes, and differentiating between MS and non-MS idiopathic inflammatory demyelinating diseases.

TL;DR: The incidence of persistent antibody positivity associated with natalizumab is 6%.

TL;DR: Gd-enhanced MR imaging appears to be more sensitive than HICT in the detection of the transient abnormalities of the blood-brain barrier that occur in patients with active MS and appears capable of distinguishing active lesions that may correspond to the anatomic regions responsible for abnormal clinical findings.

TL;DR: The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFNβ)-1a in patients with relapsing multiple sclerosis (MS) as discussed by the authors.

TL;DR: The role played by the medial longitudinal fasciculus in ocular motor physiology and to characterize a number of syndromes that result from lesions in this eloquent brainstem tract system are reviewed.